EU aims to raise market surveillance standards
This article was originally published in Clinica
The European Union is to set up a second oversight group to tighten up the implementation of the medical device directives. Following on some six months after the Notified Bodies Operations Group (NBOG) was established, the Market Surveillance Operations Group (MSOG), has now been set up.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.